There are no vitamin patches listed on the Australian Register of Therapeutic Goods and there’s not enough evidence to show they work better than tablets.
A worker sorting plastic bottles at a recycling plant in Lagos.
Pius Utomi Ekpei/AFP / Getty Images
The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
Canadians pay high drug prices, but the pharmaceutical industry claims it is a ‘key partner in economic resilience, recovery and growth.’
(Shutterstock)
Canadians pay very high drug costs, but Canada also does not receive the same economic benefits from pharmaceutical industry investments as other countries do.
Health Canada’s new drug licensing proposal contains no mechanism for making fast-tracked medicines affordable.
THE CANADIAN PRESS/Ryan Remiorz
The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.
Ozempic, a semaglutide drug being used for weight loss, could impact how society sees fat people.
(macrovector/Freepik)
Vinita Srivastava, The Conversation; Boké Saisi, The Conversation, and Kikachi Memeh, The Conversation
As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
When regulatory agencies like Health Canada approve a new drug, they require the drug company to continue monitoring the product’s safety.
(Shutterstock)
Health Canada continues to monitor newly approved drugs to determine if the benefits identified in the pre-market trials hold up to further scrutiny. Canadians need better access to that information.
If you think your medicine may be contributing to overheating, it’s very important you keep taking your medicine. Discuss your symptoms with your pharmacist or doctor.
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Despite technological advancements, many challenges remain in getting a drug from lab to pharmacy shelf. Reframing what is a “medicine” could expand treatment options for researchers and patients.